Today's Date: June 3, 2023
Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Cl   •   GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy   •   New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing   •   Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y   •   UNice Celebrates LGBTQ Pride Month   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i   •   Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting   •   LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemo   •   San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery   •   KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf   •   Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam   •   Bijou Ikli named new CEO by Florida Assisted Living Association   •   Government of Canada releases summary of actions taken to address the safety and wellbeing of Indigenous women, girls and 2SLGBT   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award
Bookmark and Share

Korelya Capital Invests in Weo, Bringing Total Funds Raised to $15M, and Leads Launch of its Series A Financing Round

Korelya Capital Invests in Weo, Bringing Total Funds Raised to $15M, and Leads Launch of its Series A Financing Round

PR Newswire

MIAMI, March 24, 2023 /PRNewswire/ -- Weo, the deep-tech startup that is revolutionizing life's most important component – water - is proud to announce that leading European venture firm, Korelya Capital, has just joined as a new shareholder, bringing the total funds raised to date to $15 million.

Weo has spent over a decade researching water and its impact on plants, animals, and human health. Its patented and eco-friendly electrolysis technology uses diamond coated silicon to activate all the biomolecules present in water enhancing their natural properties to better support immunity, vitality, gut and skin health. In line with Precision Medicine or Precision Nutrition, Weo's vision is to offer Precision Water to address any specific needs during the day and for every occasion throughout the journey of one's life.

"We are excited to partner with the first Precision Water deep-tech company and support its expansion to diverse industries, all the way from consumer goods, food, agriculture, CBD, cosmetics, to healthcare", comments Antoine Dresch, Founding partner of Korelya Capital. "Along Weo's growth, Korelya aims to consolidate its position as a strategic shareholder".

In addition to investments previously raised from high-net-worth individuals and entrepreneurs, the funding from Korelya Capital strengthens Weo's position as a breakthrough innovator in the industry. It comes as Weo's B2C product (Weo Bottle) is sales-ready and will be used to both support the launch of the consumer market and accelerate the commercial phase of its agribusiness solutions. Weo plans to positively impact the water used across the whole food chain.

"As advocates of a sustainable tech ecosystem, we have been deeply inspired by the founder's unique approach to water science and by Weo's ESG roadmap including health impact, sustainable agriculture, healthy foods, and animal welfare. We look forward to supporting the Weo team in Europe and Asia in the coming years", said Fleur Pellerin, Chairwoman and Co-founder of Korelya Capital.

"Korelya Capital's investment marks a significant milestone in Weo's development and a recognition of the remarkable progress and innovation that Weo's team has achieved over the past year", said Anthony Ginter, Founder and CEO of Weo. "We are grateful for the incredible support we have received from our initial private investors over the last two years; this new funding propels us into a new phase of growth, reinforcing our ambition to become the next deep tech champion in the US, Europe, and Asia".

About Korelya Capital

Founded and Chaired by Fleur Pellerin, former French Minister of Digital Economy and Culture, and Antoine Dresch, Korelya Capital is a late-stage venture fund with €750M under management with offices in Paris, London, Seoul and Singapore. Since its launch in 2017, Korelya Capital has notably invested in several European tech champions that became global category leaders (Wallapop, Vestiaire Collective, Glovo, Bolt, Ledger, FINN…). Korelya Capital supports European technology companies in achieving their global ambition, notably through valuable support via its extensive network in Europe and in Asia.

About Weo

Weo is a Miami-based conscientious deep-tech company generating impact by revolutionizing the way the world drinks water. With over 15 years of scientific research, their focus is improving the health and wellness of humans, animals, and plants, by enhancing the natural properties of water with their unique, eco-friendly, water calibration technology. Through its vision of Precision Water, Weo offers to provide biologically calibrated water to address any specific need – from healthy aging and exercise performance, to crop production and livestock agriculture – for daily use and throughout the journey of life.

Contact: Gilles Bazan – CMO

Cision View original content to download multimedia:


Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News